Jubilant Ingrevia has raised Rs 50 crore through issuance of Commercial Papers (CPs). Maturity of the said Commercial Papers will be on November 21, 2025.
The Finance Committee, at its meeting held on October 23, 2024 approved issuance of Commercial Papers up to an amount of Rs 600 crore outstanding at any point of time, in one or more tranches. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 100 crore.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
